Clinical Trial Update: Penn Biobank Return of Research Results Program [NA]

View source ↗

Summary

The Penn Biobank Return of Research Results Program update announces the study has completed and outlines the participating conditions including cancer, cardiov…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Cardiovascular Diseases
• Hereditary Cancer
• Hereditary Cardiac Amyloidosis

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Cancer, Cardiovascular Diseases | NA | Status: COMPLETED